Hillsdale Investment Management Inc. Ironwood Pharmaceuticals Inc Call Options Transaction History
Hillsdale Investment Management Inc.
- $1.13 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$156 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$126 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$106 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$89.9 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$46.6 Million0.16% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $990M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...